SOL SpAMIL:SOL +1.16%78 EPS without NRI is €1.86 as of Dec. 2025. GuruFocus rates MIL:SOL with a GF Score™ of 78/100 and a GF Value™ of €42.49 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,255 Chemicals companies, SOL SpA ranks better than 63.9% on this metric.
SOL SpA's earnings per share without non-recurring items for the
six
months ended in Dec. 2025 was €0.88.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €1.86.
During the past 12 months, SOL SpA's average earnings per share (NRI) Growth Rate was 13.00% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 8.30% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 12.50% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 19.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for SOL SpA's EPS without NRI or its related term are showing as below:
MIL:SOL'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -12.9 Med: 12.8 Max: 36
Current: 8.3
During the past 13 years, SOL SpA's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 36.00% per year. The lowest was -12.90% per year. And the median was 12.80% per year.
MIL:SOL's 3-Year EPS without NRI Growth Rate is ranked better than 63.9% of 1255
companies
in the Chemicals industry
Industry Median: -1.7
vs MIL:SOL: 8.30
SOL SpA's EPS (Diluted) for the
six
months ended in Dec. 2025 was €0.92.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.84.
SOL SpA's EPS (Basic) for the
six
months ended in Dec. 2025 was €0.92.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.84.
SOL SpA (MIL:SOL) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
SOL SpA EPS without NRI Related Terms
SOL SpA EPS without NRI Historical Data
* Premium members only.
The historical data trend for SOL SpA's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:SOL vs LIN, SHW, ECL: EPS without NRI Comparison
For the Specialty Chemicals subindustry, SOL SpA's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOL SpA PE Ratio without NRI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, SOL SpA's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where SOL SpA's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.86
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOL SpA (MIL:SOL) has a EPS without NRI of €1.86 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on SOL SpA and its competitors. According to the industry distribution chart, SOL SpA ranks #453 out of 1255 companies in the Chemicals industry, placing it in the top 36.1%.
Is SOL SpA's EPS without NRI too high?
SOL SpA's current EPS without NRI is €1.86. Based on the distribution chart, SOL SpA ranks #453 out of 1255 companies in the Chemicals industry, which is above the industry midpoint. Overall, SOL SpA has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOL SpA's EPS without NRI compare to LIN and SHW?
According to the Chemicals industry distribution chart, SOL SpA ranks #453 out of 1255 companies for EPS without NRI. This puts SOL SpA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on SOL SpA and its competitors. SOL SpA's current EPS without NRI is €1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOL SpA stock overvalued right now?
Based on GuruFocus' analysis, SOL SpA (MIL:SOL) is currently considered Significantly Overvalued. The stock's GF Value™ is €42.49, compared to a current price of €60.80 — trading 43.1% above its estimated fair value. The current EPS without NRI is €1.86. SOL SpA's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For SOL SpA (MIL:SOL), the current EPS without NRI is €1.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOL SpA (MIL:SOL) Overvalued in 2026?
Based on GuruFocus' analysis, SOL SpA stock appears to be overvalued.
The current stock price of €60.80 is trading 43.1% above its estimated GF Value™ of €42.49.
GuruFocus considers SOL SpA to be Significantly Overvalued.
Key valuation signals for MIL:SOL:
EPS without NRI: €1.86
GF Value™: €42.49 vs. price of €60.80 (43.1% above fair value)
No single metric tells the full story. See the MIL:SOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOL SpA manufactures and sells industrial gases and medical equipment. The firm's two segments are based on product type. The home-care segment, which generates the majority of revenue, sells a variety of medicinal gases including oxygen, nitrogen, nitrous oxide, carbon dioxide, synthetic air, and medical air. The segment also provides medical air services for hospitals. The technical gases segment sells gas-based products to the energy, agricultural, food, metalworking, glass, and electronics industries. More of SOL's revenue comes from Italy than any other country.
78GF Score
Get the complete analysis for MIL:SOL
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:SOL has been successfully added to your 
